Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for Apnea study
PACTR202303498806131Recruiting
- Sponsor
- Gates Foundation
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of caffeine and aminophylline in apnea of prematurity (AOP) (2 arms), sponsored by Gates Foundation. Started Dec 2021; status: recruiting.
02
Drugs
caffeineaminophylline
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on PACTR202303498806131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202303498806131.